Agile Therapeutics (NASDAQ:AGRX) Now Covered by StockNews.com

StockNews.com started coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Get Free Report) in a research note issued on Wednesday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Agile Therapeutics Price Performance Shares of NASDAQ AGRX opened at $1.51 on Wednesday. The firm has a market cap of $10.35 million, a […]

Leave a Reply

Your email address will not be published.

Previous post Author’s BU years inform ‘Please Come to Boston’
Next post Universal Electronics (NASDAQ:UEIC) Lowered to Hold at StockNews.com